NCT01037699View on ClinicalTrials.gov

Luteinizing Hormone (LH) Supplementation in Gonadotropin-releasing Hormone (GnRH) Antagonist Cycles

PHASE3CompletedINTERVENTIONAL
Enrollment

720

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Ovarian Stimulation
Interventions
DRUG

rFSH: Follicle Stimulating Hormone

DRUG

rFSH: Follicle Stimulating Hormone

DRUG

rFSH: Follicle Stimulating Hormone and rLH: Luteinizing Hormone (Recombinant Luteotrophin alfa)

DRUG

rFSH: Follicle Stimulating Hormone and rLH: Luteinizing Hormone (Recombinant Luteotrophin alfa)

Trial Locations (1)

46117

IVI Valencia, Valencia

All Listed Sponsors
lead

Instituto Valenciano de Infertilidad, IVI VALENCIA

OTHER

NCT01037699 - Luteinizing Hormone (LH) Supplementation in Gonadotropin-releasing Hormone (GnRH) Antagonist Cycles | Biotech Hunter | Biotech Hunter